Analysts Set Henry Schein, Inc. (NASDAQ:HSIC) Price Target at $77.50

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have received a consensus rating of “Moderate Buy” from the twelve research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $77.50.

Several research analysts have recently issued reports on HSIC shares. Robert W. Baird decreased their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. UBS Group lowered their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. StockNews.com lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday. Barrington Research reaffirmed an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Friday, September 20th. Finally, Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd.

Insider Buying and Selling

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.14% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the stock. Wealth Enhancement Advisory Services LLC increased its position in Henry Schein by 19.4% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 35,213 shares of the company’s stock valued at $2,659,000 after acquiring an additional 5,717 shares during the last quarter. First Trust Direct Indexing L.P. lifted its stake in shares of Henry Schein by 4.2% in the 1st quarter. First Trust Direct Indexing L.P. now owns 5,356 shares of the company’s stock worth $404,000 after purchasing an additional 215 shares during the period. Tempus Wealth Planning LLC boosted its stake in shares of Henry Schein by 10.0% during the 1st quarter. Tempus Wealth Planning LLC now owns 4,347 shares of the company’s stock worth $328,000 after acquiring an additional 394 shares during the last quarter. New Century Financial Group LLC grew its position in shares of Henry Schein by 15.7% during the 1st quarter. New Century Financial Group LLC now owns 4,575 shares of the company’s stock valued at $346,000 after acquiring an additional 620 shares during the period. Finally, Everett Harris & Co. CA increased its stake in shares of Henry Schein by 13.9% in the 1st quarter. Everett Harris & Co. CA now owns 119,257 shares of the company’s stock worth $9,006,000 after purchasing an additional 14,580 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $70.64 on Monday. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The firm’s fifty day simple moving average is $70.62 and its 200 day simple moving average is $69.78. The stock has a market cap of $9.05 billion, a P/E ratio of 23.86, a price-to-earnings-growth ratio of 2.00 and a beta of 0.86. Henry Schein has a twelve month low of $60.01 and a twelve month high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.10 billion for the quarter, compared to analysts’ expectations of $3.27 billion. During the same quarter in the previous year, the company earned $1.31 earnings per share. Henry Schein’s quarterly revenue was up .0% on a year-over-year basis. As a group, research analysts predict that Henry Schein will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.